Derivation of a biologically contained replication system for human immunodeficiency virus type 1

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Human immunodeficiency virus type 1 (HIV-1) requires specific regulatory genes for replication.
• Proviral mutants lacking these genes cannot replicate independently and require complementation in trans.
• Recombinant cell lines expressing deficient genes can produce structurally intact, yet replication-restricted, virus.

Purpose of the Study:

• To describe a novel HIV-1 mutant (vIIIB delta Tat/Rev) functionally defective in tat and rev genes.
• To demonstrate the utility of a recombinant T-cell line (CEMTART) for the replication and study of this defective mutant.
• To establish a safe and contained system for analyzing HIV-1 genotypes and developing antiviral agents.

Main Methods:

• Construction of an HIV-1 mutant (vIIIB delta Tat/Rev) lacking functional tat and rev genes.
• Generation of a recombinant T-cell line (CEMTART) expressing tat and rev genes.
• Infection of CEMTART with vIIIB delta Tat/Rev to enable viral replication and analysis.
• Assessment of viral replication, cytopathology, CD4 expression, and viral protein production.
• Sequencing and replication assays to confirm the absence of reversion to wild-type HIV-1.

Main Results:

• Infection of CEMTART with vIIIB delta Tat/Rev supported the complete HIV-1 life cycle, including cytopathology and CD4 downregulation.
• Culture supernatants contained replication-competent virus that could only infect CEMTART cells.
• No reversion to wild-type HIV-1 was detected through sequencing or replication assays in standard T lymphocytes.
• The system allowed for the preparation of authentic HIV-1 structural proteins and infected cells in mass.

Conclusions:

• Defective HIV-1 mutants complemented in trans provide a biologically contained system for studying viral replication and function.
• This approach facilitates large-scale analysis of defined HIV-1 genotypes and their impact on cellular phenotype.
• It offers a safer method for preparing viral components and screening antiviral agents with minimal risk to laboratory personnel.